Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 24, 2008, Pages 8363-8368

  King, Christopher L ^a,b   Michon, Pascal ^c   Shakri, Ahmad Rushdi ^d   Marcotty, Alexandra ^a,b   Stanisic, Danielle ^c,e   Zimmerman, Peter A ^a   Cole Tobian, Jennifer L ^a,b   Mueller, Ivo ^c   Chitnis, Chetan E ^d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veterans Affairs Research Service   (United States)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Duffy antigen; Immunity; Protective antibodies

Indexed keywords

ANTIBODY; ANTIGEN; DUFFY BINDING PROTEIN;

ADOLESCENT; ANTIBODY SPECIFICITY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENDEMIC DISEASE; ERYTHROCYTE; FEMALE; HAPLOTYPE; HOST CELL; HUMAN; IMMUNITY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALARIA; MALE; MICROSCOPY; NONHUMAN; PAPUA NEW GUINEA; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; REINFECTION; RISK REDUCTION; SCHOOL CHILD;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALARIA VACCINES; MALARIA, VIVAX; MALE; NEW GUINEA; PLASMODIUM VIVAX; PROSPECTIVE STUDIES; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE;

PLASMODIUM VIVAX;

EID: 46149123863     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0800371105     Document Type: Article

References (24)

1. Baird JK (1995) Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 11:105-111.
2. Marsh K, Kinyanjui S (2006) Immune effector mechanisms in malaria. Parasite Immunol 28:51-60.
3. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE (2006) Immune responses to asexual blood-stages of malaria parasites. Curr Mol Med 6:187-203.
4. Miller LH, Mason SJ, Clyde DF, McGinniss MH (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295:302-304.
5. Kasehagen LJ, et al. (2007) Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS ONE 2:e336.
6. Adams JH, et al. (1992) A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA 89:7085-7089.
7. Chitnis CE, Miller LH (1994) Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 180:497-506.
8. Wertheimer SP, Barnwell JW (1989) Plasmodium vivax interaction with the human Duffy blood group glycoprotein: Identification of a parasite receptor-like protein. Exp Parasitol 69:340-350.
9. Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH (1996) The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 184:1531-1536.
10. Ranjan A, Chitnis CE (1999) Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. Proc Natl Acad Sci USA 96:14067-14072.
11. Grimberg BT, et al. (2007) Antibodies directed Plasmodium vivax Duffy binding protein region inhibit P. vivax invasion of human erythrocytes. PLoS Medicine 4:e337.
12. Choe H, et al. (2005) Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol Microbiol 55:1413-1422.
13. Michon P, et al. (2007) The risk of malarial Infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76:997-1008.
14. Cole-Tobian JL, Michon P, Dabod E, Mueller I, King CL (2007) Dynamics of asymptomatic Plasmodium vivax infections and Duffy binding protein polymorphisms in relation to parasitemia levels in Papua New Guinean children. Am J Trop Med Hyg 77:955-962.
15. Xainli J, Adams JH, King CL (2000) The erythrocyte binding motif of plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol Biochem Parasitol 111:253-260.
16. Saul A (2007) Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3-Should we avoid amino acid sequence polymorphisms or embrace them? J Infect Dis 195:171-173.
17. Sutherland CA (2007) challenge for the development of malaria vaccines: Polymorphic target antigens. PLoS Med 4:e116.
18. Adams JH, et al. (1990) The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63:141-153.
19. VanBuskirk KM, Sevova E, Adams JH (2004) Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc Natl Acad Sci USA 101:15754-15759.
20. McNamara DT, et al. (2006) Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay Am J Trop Med Hyg 74:413-421.
21. Perandin F, et al. (2004) Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol 42:1214-1219.
22. Cole-Tobian JL, Zimmerman PA, King CL (2007) High-throughput identification of the predominant malaria parasite clone in complex blood stage infections using a multi-SNP molecular haplotyping assay. Am J Trop Med Hyg 76:12-19.
23. Hans D, et al. (2005) Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol Microbiol 55:1423-1434.
24. McElroy PD, et al. (1999) Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. Am J Trop Med Hyg 61:932-940.